B
Bengt Larsson
Researcher at University of Gothenburg
Publications - 184
Citations - 6506
Bengt Larsson is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Melanin & Nitric oxide synthase. The author has an hindex of 43, co-authored 180 publications receiving 6181 citations. Previous affiliations of Bengt Larsson include AstraZeneca & National Veterinary Institute.
Papers
More filters
Journal ArticleDOI
Interaction Between Chemicals and Melanin
TL;DR: Various drugs and other chemicals, such as organic amines, metals, polycyclic aromatic hydrocarbons, etc., are bound to melanin and retained in pigmented tissues for long periods and there are many indications of a connection between the melanin affinity of these agents and the induction of malignant melanoma.
Journal ArticleDOI
Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats.
TL;DR: The present study uses autoradiography and gamma spectrometry to show that intranasal instillation of manganese in rats results in initial uptake of the metal in the olfactory bulbs, and proposes that the neurotoxicity of inhaledManganese can circumvent the blood-brain barrier and gain direct access to the central nervous system.
Journal ArticleDOI
Studies on the mechanism of drug-binding to melanin.
Bengt Larsson,Hans Tjälve +1 more
TL;DR: It is suggested that melanin may be able to oxidize chlorpromazine to a positive ion radical, explaining the firm binding of the substance to melanin and the evidence in the literature favouring this possibility are discussed.
Journal ArticleDOI
Immunohistochemical localization of peripheral nitric oxide synthase-containing nerves using antibodies raised against synthesized C- and N-terminal fragments of a cloned enzyme from rat brain.
TL;DR: Antibodies were raised in rabbits against C- or N-terminal fragments of a cloned nitric oxide synthase (NOS) enzyme from rat cerebellum and used for demonstration of NOS-immunoreactive (Nos-IR) nerves in different tissues from the rat, which demonstrated the same neuronal elements, although with differences in intensity in the immunoreaction in some tissues.
Journal ArticleDOI
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial.
Paul M. O'Byrne,Hristo Metev,Margareta Puu,Kai Richter,Christina Keen,Mohib Uddin,Bengt Larsson,Marie Cullberg,Parameswaran Nair +8 more
TL;DR: Treatment with this selective CXCR2 antagonist did not reduce the frequency of severe exacerbations in patients with uncontrolled severe asthma, and this findings bring into question the role of CX CR2-mediated neutrophil recruitment in the pathobiology of exacerbation in severe refractory asthma.